332 related articles for article (PubMed ID: 8437502)
1. [Axillary recurrence after lymph node excision in malignant melanoma].
Kretschmer L; Lautenschläger C; Preusser KP; Fiedler H; Hetschko I
Langenbecks Arch Chir; 1993; 378(1):4-11. PubMed ID: 8437502
[TBL] [Abstract][Full Text] [Related]
2. [Inguinal recurrence after therapeutic lymphadenectomy in malignant melanoma].
Kretschmer L; Lautenschläger C; Preusser KP; Fiedler H
Langenbecks Arch Chir; 1993; 378(4):211-6. PubMed ID: 8366734
[TBL] [Abstract][Full Text] [Related]
3. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant irradiation for axillary metastases from malignant melanoma.
Ballo MT; Strom EA; Zagars GK; Bedikian AY; Prieto VG; Mansfield PF; Lee JE; Gershenwald JE; Ross MI
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):964-72. PubMed ID: 11958890
[TBL] [Abstract][Full Text] [Related]
5. Lymph node dissection for clinically evident lymph node metastases of malignant melanoma.
Meyer T; Merkel S; Göhl J; Hohenberger W
Eur J Surg Oncol; 2002 Jun; 28(4):424-30. PubMed ID: 12099654
[TBL] [Abstract][Full Text] [Related]
6. [Preventive lymph node excision in the treatment concept of melanoma of the extremities].
Binder J; Henneking K
Zentralbl Chir; 1996; 121(6):474-7. PubMed ID: 8767334
[TBL] [Abstract][Full Text] [Related]
7. Stage III thick (>4.0 mm) lower extremity melanoma: is timing of lymph node involvement a prognostic factor?
Herman K; Wysocki WM; Skotnicki P; Tabor J; Luczyńska E; Komorowski AL
World J Surg; 2009 Mar; 33(3):469-74. PubMed ID: 19148700
[TBL] [Abstract][Full Text] [Related]
8. Lymph node ratio has impact on relapse and outcome in patients with stage III melanoma.
Tas F; Erturk K
Int J Clin Oncol; 2019 Jun; 24(6):721-726. PubMed ID: 30788673
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis.
White RR; Stanley WE; Johnson JL; Tyler DS; Seigler HF
Ann Surg; 2002 Jun; 235(6):879-87. PubMed ID: 12035046
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma.
Essner R; Conforti A; Kelley MC; Wanek L; Stern S; Glass E; Morton DL
Ann Surg Oncol; 1999; 6(5):442-9. PubMed ID: 10458681
[TBL] [Abstract][Full Text] [Related]
12. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.
Lee RJ; Gibbs JF; Proulx GM; Kollmorgen DR; Jia C; Kraybill WG
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):467-74. PubMed ID: 10661355
[TBL] [Abstract][Full Text] [Related]
13. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.
Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM
Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828
[TBL] [Abstract][Full Text] [Related]
14. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
[TBL] [Abstract][Full Text] [Related]
15. Number of Excised Lymph Nodes Has No Impact on Relapse and Survival in Patients With Stage III Melanoma.
Tas F; Erturk K
Ann Plast Surg; 2019 Oct; 83(4):455-458. PubMed ID: 31524742
[TBL] [Abstract][Full Text] [Related]
16. [Long-term results of adjuvant chemotherapy after therapeutic lymph node dissection in patients with cutaneous malignant melanoma].
Kretschmer L; Helmbold P; Emmert S; Marsch WC
Hautarzt; 2002 Aug; 53(8):536-41. PubMed ID: 12221468
[TBL] [Abstract][Full Text] [Related]
17. Sentinel-node biopsy or nodal observation in melanoma.
Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
[TBL] [Abstract][Full Text] [Related]
18. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.
Gershenwald JE; Colome MI; Lee JE; Mansfield PF; Tseng C; Lee JJ; Balch CM; Ross MI
J Clin Oncol; 1998 Jun; 16(6):2253-60. PubMed ID: 9626228
[TBL] [Abstract][Full Text] [Related]
19. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.
Agrawal S; Kane JM; Guadagnolo BA; Kraybill WG; Ballo MT
Cancer; 2009 Dec; 115(24):5836-44. PubMed ID: 19701906
[TBL] [Abstract][Full Text] [Related]
20. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
Fisher SR
Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
